Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
PT

PTGX

Market Closed

Protagonist Therapeutics, Inc.

NASDAQHealthcareBiotechnology
US
141 employees
CEO: Dinesh V. Patel
Founded: 2016
$144.12
+$0.00(+NaN%)
Market Cap
9.27B
Beta
1.79
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
97.3%
-89.7%
CAGR: 13.1%

Profit after direct costs

Operating Margin
-343.6%
-162.5%
CAGR: N/A

Core business profitability

Net Margin
-282.8%
-147.3%
CAGR: N/A

Bottom line profitability

Revenue Growth
-89.4%
YoY
CAGR: 13.9%

Top line growth rate

Revenue Flow Analysis
Visual flow showing how PTGX allocates revenue across expenses and profit
Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin
97.3%
$44.79M
Operating Margin
-343.6%
$-158.13M
Net Margin
-282.8%
$-130.15M
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
ItemTrend20212022202320242025YoY Change
Total Revenue
27.36M26.58M60.00M434.43M46.02M-89.4%
Cost of Revenue
————(1.23M)—
Gross Profit
27.36M26.58M60.00M434.43M44.79M-89.7%
Operating Expenses
Research & Development
(126.01M)(126.22M)(120.16M)(138.13M)(159.29M)15.3%
Selling, General & Administrative
(27.20M)(31.74M)(33.49M)(43.46M)(44.85M)3.2%
General & Administrative
(27.20M)(31.74M)(33.49M)(43.46M)(44.85M)3.2%
Depreciation & Amortization
(2.77M)(3.37M)(3.31M)(826.00K)(1.23M)48.3%
Operating Income (EBIT)
-125.84M-131.37M-93.65M252.84M-158.13M-162.5%
Non-Operating Items
Interest Income
443.00K4.06M14.90M26.32M28.79M9.4%
Interest Expense
——————
Other Income/Expenses (Net)
294.00K3.98M14.70M26.57M28.82M8.5%
Income Before Tax
-125.55M-127.39M-78.95M279.41M-129.31M-146.3%
Income Tax Expense
———(4.22M)(838.00K)-80.1%
Net Income
-125.55M-127.39M-78.95M275.19M-130.15M-147.3%
Per Share Metrics
Earnings Per Share (Basic)
$-3$-3$-1$4$-2-145.9%
Weighted Avg Shares Outstanding
46.32M49.04M56.76M61.57M63.57M3.3%
Weighted Avg Shares Outstanding (Diluted)
46.32M49.04M56.76M65.08M63.57M-2.3%
EBITDA
-122.78M-124.02M-75.64M280.23M-128.09M-145.7%

Explore PTGX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PTGX in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →